Sandoz to Pay Nearly $480 Million to Settle US Antitrust Lawsuits

Swiss pharmaceutical company Sandoz has agreed to pay approximately $480 million to resolve long-standing antitrust litigation in the United States. The settlement addresses allegations of price-fixing and other anti-competitive practices.

3 Aug, 07:02 — 3 Aug, 07:02

Post Share

Sources

Showing 1 of 2 sources

wsjHigh2h ago

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations - WSJ

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations WSJ

Read full article →

Coverage Timeline

First report: wsj · 3 Aug, 07:02|Full coverage: 2 · 3m|Window: 3m

Left-leaningCenterRight-leaning

wsj3 Aug, 07:02First to report

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations - WSJ

swissinfo3 Aug, 07:05Latest update

PERSPECTA

PERSPECTA

Sandoz to Pay Nearly $480 Million to Settle US Antitrust Lawsuits

Sources

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations - WSJ

Coverage Timeline

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations - WSJ

Swiss pharma firm Sandoz to pay $450 million in US antitrust suit - SWI swissinfo.ch

Related Stories

Calls Intensify to Ban Meta Glasses in Germany

Patos Residents Protest Against Merger with Fier Municipality

Serbia: Property Tax Payment Issues Due to Incorrect Cadastral Data

Hate Speech Unsanctioned in Montenegro Parliament

PERSPECTA